Home / Research / Manufacturers / Nanosphere, Inc. Medical-device intelligence
Nanosphere, Inc.: FDA clearances and recalls Research Nanosphere, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
Names and coverage This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
Names observed in the source
Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.
Product codes in this company’s records Record activity in this scope 15 clearance records and 12 recall records in the covered releases, across 1 source company names and 10 product codes. Dated history runs from Sep 17, 2007 to Sep 4, 2015.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 0 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 27 matching records Device / record Company in FDA record Source Source date Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) K143653 · OCCNanosphere, Inc. 510(k) Sep 4, 2015FDA decision date Verigene BC-GP Kit (Catalog number 20-005-018); 1) 20 Verigene BC-GP Test Cartridges; are qualitative multiplexed in vitro diagnostic tests for s… Z-2735-2014 · PAMNanosphere, Inc. Recall Sep 30, 2014FDA classification date Verigene BC-GN Kit (Catalog number 20-005-021); 1) 20 Verigene BC-GN Test Cartridges; are qualitative multiplexed in vitro diagnostic tests for s… Z-2736-2014 · PENNanosphere, Inc. Recall Sep 30, 2014FDA classification date The Verigene Gram Negative Blood Culture Nucleic Acid Test (BC-GN), performed using the sample-to-result Verigene System, is a qualitative multip… Z-2681-2014 · PENNanosphere, Inc. Recall Sep 23, 2014FDA classification date The Verigene Clostridium difficile Nucleic Acid Test (CDF) is a qualitative, multiplexed in vitro diagnostic test for the rapid detection of toxi… Z-2682-2014 · OZNNanosphere, Inc. Recall Sep 23, 2014FDA classification date The Verigene Gram-Positive Blood Culture Nucleic Acid Test (BC-UP) performed using the sample-to-result Verigene System is a qualitative, multipl… Z-2683-2014 · PAMNanosphere, Inc. Recall Sep 23, 2014FDA classification date The Verigene Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene System is a qualitative nucleic acid multiplex test intended to simul… Z-2684-2014 · OCCNanosphere, Inc. Recall Sep 23, 2014FDA classification date The Verigene Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualitative test for simultaneous detection and identification of common … Z-2685-2014 · PCHNanosphere, Inc. Recall Sep 23, 2014FDA classification date Verigene CYP2C19 Nucleic Acid Test (CYP2C19 Test). Each CYP2C19 kit consists of 20 Verigene CYP2C19 Nucleic Acid Test Cartridges and 20 Verigene… Z-2559-2014 · NTINanosphere, Inc. Recall Aug 28, 2014FDA classification date Verigene BC-GN Test Kit (Catalog number 20-005-021) includes: 1) 20 Verigene BC-GN Test Cartridges. Each Test Cartridge comes preloaded with all … Z-2236-2014 · PENNanosphere, Inc. Recall Aug 14, 2014FDA classification date Nanosphere Verigene
Each CDF test consists of a Verigene CDF Nucleic Acid Test Kit and a Verigene CDF Amplification Reagent Kit.
The Veri… Z-2168-2014 · OZNNanosphere, Inc. Recall Aug 8, 2014FDA classification date Verigene Gram-Negative Blood Culture Nucleic Acid Test (BC-GN), performed using the sample-to-result Verigene System, is a qualitative multiplexe… Z-2170-2014 · PENNanosphere, Inc. Recall Aug 8, 2014FDA classification date VERIGENE ENTERIC PATHOGEN NUCLEIC ACID TEST ( EP) K140083 · PCHNanosphere, Inc. 510(k) Jun 20, 2014FDA decision date VERIGENE GRAM NEGATIVE BLOOD CULTURE NUCLEIC ACID TEST (BC-GN) K132843 · PENNanosphere, Inc. 510(k) Jan 8, 2014FDA decision date VERIGENE C. DIFFICILE NUCLEIC ACID TEST (CDF) K123197 · OZNNanosphere, Inc. 510(k) Dec 5, 2012FDA decision date VERIGENE CYP2C19 NUCLEIC ACID TES (2C19) K120466 · NTINanosphere, Inc. 510(k) Nov 6, 2012FDA decision date VERIGENE GRAM-POSITIVE BLOOD CULTURE (GC-GP) NUCLEIC ACID TEST K122514 · PAMNanosphere, Inc. 510(k) Sep 19, 2012FDA decision date VERIGENE STAPHYLOCOCCUS BLOOD CULTURE NUCLEIC ACID TEST (BC-S) K112424 · NQXNanosphere, Inc. 510(k) Dec 16, 2011FDA decision date VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST +(RVNAT+) K103209 · OCCNanosphere, Inc. 510(k) Jan 10, 2011FDA decision date VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST ON THE VERIGENE SP SYSTEM K093337 · OCCNanosphere, Inc. 510(k) Nov 17, 2009FDA decision date VERIGENE SYSTEM, VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST K092957 · OCCNanosphere, Inc. 510(k) Oct 21, 2009FDA decision date VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST ON THE VERIGENE SP SYSTEM (RVNATSP) K092566 · OCCNanosphere, Inc. 510(k) Oct 9, 2009FDA decision date VERIGENE CFTR NUCLEIC ACID TEST AND VERIGENE CFTR POLYT NUCLEIC ACID TEST K083294 · NUANanosphere, Inc. 510(k) Jul 24, 2009FDA decision date VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST K083088 · OCCNanosphere, Inc. 510(k) May 1, 2009FDA decision date Warfarin Metabolism Nucleic Acid Test Cartridge; Part Number: 20-006-002; an in vitro diagnostic drug metabolizing enzyme genotyping system; Nano… Z-1383-2008 · ODWNanosphere, Inc. Recall Mar 31, 2008FDA classification date
Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗